1-ethyl-2-benzimidazolinone has been researched along with nitroarginine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aso, T; Azuma, H; Iwasaki-Kurashige, K; Loyaga-Rendon, RY; Sakamoto, S; Takahashi, R | 1 |
| Kamata, K; Kobayashi, T; Matsumoto, T | 1 |
2 other study(ies) available for 1-ethyl-2-benzimidazolinone and nitroarginine
| Article | Year |
|---|---|
Mediators involved in decreasing peripheral vascular resistance with carbachol in the rat hind limb perfusion model.
Topics: Animals; Benzimidazoles; Carbachol; Cyclic GMP; Endothelium, Vascular; Female; Gap Junctions; Hindlimb; Nitric Oxide; Nitroarginine; Nitroprusside; Perfusion; Potassium Chloride; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasodilation | 2005 |
Mechanisms underlying the impaired EDHF-type relaxation response in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Topics: Acetylcholine; Animals; Benzimidazoles; Biological Factors; Blood Glucose; Body Weight; Calcium Channel Agonists; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mesenteric Arteries; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Phosphodiesterase Inhibitors; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Vasodilation; Vasodilator Agents | 2006 |